10 results
Medium Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - MEDIUM / ELEVATED risk (range low
Medium Risk Aspirin ... elevated - high) #Management ... #Primary #Prevention ... #DecisionAid #PatientInfo ... #HeartAttack #Bleeding
High Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - HIGH risk (range low - elevated
High Risk Aspirin ... elevated - high) #Management ... #Primary #Prevention ... #DecisionAid #PatientInfo ... #HeartAttack #Bleeding
Low Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - LOW / AVERAGE risk (range low
Low Risk Aspirin ... elevated - high) #Management ... #Primary #Prevention ... #DecisionAid #PatientInfo ... #HeartAttack #Bleeding
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
CNS Manifestations ... Ischemic Pathway - Aspirin ... APS), Secondary prevention ... #neurology #rheumatology ... cerebritis #diagnosis #management
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
Diagnosis and Management ... of symptoms and prevention ... • Aspirin should ... PV #Diagnosis #Management ... #hematology
Disseminated Intravascular Coagulation (DIC) Overview

Increased Clotting and Consumption of Clotting Factors

Findings:
 • Bleeding
 • Recent history
Thromboembolism (7%) • CNS ... Treatment: ... • Treat primary ... diagnosis #causes #treatment ... #management #hematology
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
nervous system (CNS ... purpura to mucosal bleeding ... Treatment: • Corticosteroids ... Syndrome #Diagnosis #Management ... #Hematology #Rheumatology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
of symptoms and prevention ... Hydroxyurea + aspirin ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
• 8%-27% for CNS ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
Hemophagocytic Lymphohistiocytosis (HLH) Treatment
Primary HLH:
 - HLH-94 Protocol
    • Dexamethasone
Lymphohistiocytosis (HLH) Treatment ... Primary HLH: - ... (depending on CNS ... autoimmune disease, treatment ... #management #hematology